Scientists have achieved the first DNA-free CRISPR gene editing in raspberries, reaching 19% efficiency and opening the door to faster breeding of firmer, more resilient berries — though regenerating ...

CRISPR Therapeutics gains momentum with Casgevy sales and a broader pipeline, while Beam Therapeutics advances base-editing therapies still in early stages.

CRSP is a speculative buy for aggressive investors, driven by the commercial launch and multibillion-dollar potential of ...

Macquarie University researchers used CRISPR technology to challenge textbook explanations for why albinism is rare in nature ...

Macquarie University researchers used advanced gene-editing technology to debunk long-held beliefs about why albinism is rare ...

Honeybee populations facing severe challenges are now being helped by the development of a bee superfood using technology ...

On paper it sounds great: no more pigs being susceptible for PRRS. No more diseased pigs, no more suffering and considerable efficiency gains. Made ...

NtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering technology, it has now completed the filing of two patents for a ...

Another major buy was in INTELLIA THERAPEUTICS INC (NASDAQ:NTLA), with ARK purchasing 191,705 shares for around $2.18 million through its ARKK ETF. Similar to CRISPR, INTELLIA has seen increased ...

There were more than 48,000 organ transplants in the U.S. in 2024, a 3.3% increase from 2023, according to Organ Procurement ...

The surgeons at Guangzhou Medical University performed this ground-breaking procedure, transplanting the left lung of a specially modified pig into a 39-year-old man who had been declared brain dead a ...